Kousoulas; Konstantin G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kousoulas; Konstantin G..The latest application filed is for "vaccines against genital herpes simplex infections".

Company Profile

0.10.16

Kousoulas; Konstantin G. - Baton Rouge LA
Kousoulas, Konstantin G - Baton Rouge LA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Vaccines Against Genital Herpes Simplex Infections App 20220241401 - Kousoulas; Konstantin G.	2022-08-04
Vaccines against genital herpes simplex infections Grant 11,229,697 - Kousoulas January 25, 2	2022-01-25
Compositions Comprising Herpes Simplex Virus-i For Use In Methods Of Treating And Preventing Cancer App 20210315984 - Kousoulas; Konstantin G. ; et al.	2021-10-14
Vaccines Against Genital Herpes Simplex Infections App 20200345836 - Kousoulas; Konstantin G.	2020-11-05
Vaccines against genital herpes simplex infections Grant 10,596,253 - Kousoulas	2020-03-24
Herpes simplex virus type-1(HSV-1) vaccine strain VC2 generating an anti-EHV-1 immune response Grant 10,328,147 - Kousoulas	2019-06-25
Vaccines Against Genital Herpes Simplex Infections App 20190091327 - Kousoulas; Konstantin G.	2019-03-28
Vaccines against genital herpes simplex infections Grant 10,130,703 - Kousoulas November 20, 2	2018-11-20
Herpes Simplex Virus Type-1(hsv-1) Vaccine Strain Vc2 Generating An Anti-ehv-1 Immune Response App 20180271974 - Kousoulas; Konstantin G.	2018-09-27
Vaccines Against Genital Herpes Simplex Infections App 20170266275 - Kousoulas; Konstantin G.	2017-09-21
Synthetic herpes simplex viruses type-1 for treatment of cancers Grant 8,586,028 - Kousoulas November 19, 2	2013-11-19
Synthetic Herpes Simplex Viruses for Treatment of Cancers App 20130202639 - Kousoulas; Konstantin G. ; et al.	2013-08-08
Synthetic Herpes Simplex Viruses Type-1 for Treatment of Cancers App 20100297085 - Kousoulas; Konstantin G.	2010-11-25
Vaccines for Chlamydia psittaci infections Grant 7,279,171 - Kousoulas , et al. October 9, 2	2007-10-09
Therapeutic delivery compositions and methods of use thereof Grant 7,202,225 - Emanuele , et al. April 10, 2	2007-04-10
Therapeutic delivery compositions and methods of use thereof Grant 6,933,286 - Emanuele , et al. August 23, 2	2005-08-23
Vaccines for Chlamydia psittaci infections App 20050037019 - Kousoulas, Konstantin G. ; et al.	2005-02-17
Therapeutic delivery compositions and methods of use thereof App 20040248833 - Emanuele, R Martin ; et al.	2004-12-09
Vaccines for Chlamydia psittaci infections Grant 6,605,287 - Kousoulas , et al. August 12, 2	2003-08-12
Vaccines For Chlamydia Psittaci Infections App 20020136742 - KOUSOULAS, KONSTANTIN G. ; et al.	2002-09-26
Therapeutic delivery compositions and methods of use thereof App 20020128218 - Emanuele, R. Martin ; et al.	2002-09-12
Therapeutic delivery compositions and methods of use thereof App 20020123476 - Emanuele, R. Martin ; et al.	2002-09-05

Company Registrations

NCAGE Code	473J4	KOUSOULAS KONSTANTIN G
CAGE Code	473J4	KOUSOULAS, KONSTANTIN G
DUNS	609713925	KOUSOULAS, KONSTANTIN G

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.